Mosaic ImmunoEngineering, Inc. (CPMV)
PNK · Healthcare · Biotechnology
$0.67
+0.00%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$4.9M
Shares Outstanding
7.2M
Exchange
PNK
Currency
USD
About Mosaic ImmunoEngineering, Inc.
Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. The company engages in pursuing new product candidates and platforms to build a pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -149K | -144K | -148K | -155K |
| Net Income | -172K | -165K | -169K | -175K |
| Diluted EPS | $-0.02 | $-0.02 | $nan | $-0.02 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.6M | -1.4M | -880K | -616K |
| Net Income | -2.4M | -1.0M | -922K | -688K |
| Diluted EPS | $-0.33 | $-0.14 | $-0.13 | $-0.10 |